Very good news Dr.Adams $$
Dear Friend;
Attached is today’s news release, which reports on a number of regulatory audits that the Company has undergone recently to preserve its licenses to sell the VMS+ in Canada, USA, Europe and the UK. The medial device industry is carefully monitored and guidelines for continuous verification of compliance with regulations have recently updated so everyone selling or developing medical devices has to undergo more stringent audits to re-certify their existing devices. Venrtipoint has now passed all these audits. This allows the Company to continue to sell and support VMS+ models being used in leading hospitals in Canada, USA, Europe and the UK as well as to apply for approvals for the latest premium VMS+ model, version 4.0, in Europe and the UK. The VMS+4.0 has already been licensed for sale by Health Canada and is under review by the US-FDA.
I remind you the Company has four VMS+ models currently being used or sold around thew world:
VMS+3.0 - basic model for semi-automated analysis of all 4 chambers of the heart for patients without electronic heart devices such as pacemakers or defibrillators;
VMS+3.2 - advanced model for semi-automated analysis of all 4 chambers of the heart for all patients including those with electronic heart devices such as pacemakers or defibrillators;
VMS+4.0 - premium model for automated analysis of all 4 chambers of the heart for all patients including those with electronic heart devices such as pacemakers or defibrillators;
QMS - basic model for semi-automated analysis of the right ventricle (RV) of the heart for patients without electronic heart devices such as pacemakers or defibrillators, which is manufactured and sold in China by our partner Yutian.
Thank for the support and interest as we continue to improve cardiac diagnostics for everyone, everywhere and especially for children born with heart defects.